Trial · NCT00228267
Propofol Injection for Daily Headache
NCT00228267, Phase 2, Completed, University of Alberta
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Propofol Injection for Daily Headache. Trials, record NCT00228267. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00228267
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Propofol Injection for Daily Headache
- NCT number
- NCT00228267
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 28 participants, estimated
- Lead sponsor
- University of Alberta
- Conditions
- Chronic Headache, Analgesic Rebound Headache, Chronic Daily Headache, Headache, Intractable
- Interventions
- Propofol
- First posted
- 2005-09-28
- Last updated
- 2017-05-04
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Headache Disability Index and the Headache Index | ||
| Primary | The baseline Headache Index is the mean of all 28 NRS pain scores (four measures daily for seven days) and the post-treatment Headache Index is the mean of all 120 NRS pain scores (four measures daily for thirty days) | ||
| Secondary | Number of days with a headache of at least moderate severity defined as pain at least 5 on the Numerical Rating Scale (NRS). | ||
| Secondary | Peak daily headache severity according to the NRS. | ||
| Secondary | Analgesic medication consumption will be measured in terms of morphine equivalents of narcotic medication and number of tablets /doses of acetaminophen / non-steroidal anti-inflammatory (NSAID) containing analgesics.53 | ||
| Secondary | Visits to the Emergency Room for headache treatment. | ||
| Secondary | Sedation and nausea scores in the treatment and placebo groups. | ||
| Secondary | Ability of participants in each of the groups to correctly guess their treatment assignment. | ||
| Secondary | Adverse effects related to the infusion |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 19923528 | RESULT |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00228267
GET https://conductscience.org/api/trials/v1/NCT00228267/registered